Estradiol-based postmenopausal hormone therapy and risk of cardiovascular and all-cause mortality

Conclusions: In absolute terms, the risk reductions mean 19 fewer CHD deaths and 7 fewer stroke deaths per 1,000 women using any HT for at least 10 years.
Source: Menopause - Category: OBGYN Tags: Original Articles Source Type: research